Adma Biologics, Inc. financial data

Symbol
ADMA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
C/O Adma Biologics, Inc., 465 State Route 17, Ramsey, NJ
State of incorporation
DE
Fiscal year end
December 31
Former names
R&R ACQUISITION VI, INC (to 2/21/2012)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 588 % -6.83%
Quick Ratio 367 % -8.56%
Debt-to-equity 124 % -14.6%
Return On Equity 22.1 %
Return On Assets 9.9 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 233M shares +3.64%
Common Stock, Shares, Outstanding 233M shares +3.79%
Entity Public Float 794M USD +113%
Common Stock, Value, Issued 23K USD +2.44%
Weighted Average Number of Shares Outstanding, Basic 232M shares +4.37%
Weighted Average Number of Shares Outstanding, Diluted 242M shares +8.75%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 330M USD +58.7%
Cost of Revenue 178M USD +17.8%
Research and Development Expense 2.05M USD -53.1%
Operating Income (Loss) 83.9M USD
Nonoperating Income (Expense) -44.8M USD -89.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 35.9M USD
Income Tax Expense (Benefit) 3.79M USD
Net Income (Loss) Attributable to Parent 34.8M USD
Earnings Per Share, Basic 0.15 USD/shares
Earnings Per Share, Diluted 0.14 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 88.2M USD +41.2%
Accounts Receivable, after Allowance for Credit Loss, Current 30.1M USD -18%
Inventory, Net 180M USD +11.1%
Assets, Current 304M USD +14.1%
Property, Plant and Equipment, Net 54.3M USD -3.52%
Operating Lease, Right-of-Use Asset 9.15M USD -8.52%
Intangible Assets, Net (Excluding Goodwill) 479K USD -27%
Goodwill 3.53M USD +0.01%
Assets 376M USD +9.73%
Accounts Payable, Current 14.2M USD +17.3%
Contract with Customer, Liability, Current 1.13M USD +691%
Liabilities, Current 44.2M USD +5.3%
Operating Lease, Liability, Noncurrent 9.18M USD -10.2%
Other Liabilities, Noncurrent 390K USD -13.2%
Liabilities 188M USD -4.15%
Retained Earnings (Accumulated Deficit) -456M USD +7.08%
Stockholders' Equity Attributable to Parent 188M USD +28.3%
Liabilities and Equity 376M USD +9.73%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.22M USD +84.9%
Net Cash Provided by (Used in) Financing Activities -1.45M USD -123%
Net Cash Provided by (Used in) Investing Activities -2.36M USD -21.4%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 233M shares +3.79%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -6.03M USD +65.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 88.2M USD +41.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 584K USD -87.4%
Deferred Tax Assets, Valuation Allowance 101M USD +4.86%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Deferred Tax Assets, Gross 101M USD +4.86%
Payments to Acquire Property, Plant, and Equipment 2.35M USD +20.7%
Lessee, Operating Lease, Liability, to be Paid 16.1M USD -12.3%
Property, Plant and Equipment, Gross 84.9M USD +6.75%
Operating Lease, Liability, Current 1.14M USD +16.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.16M USD -8.85%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.42M USD +3.32%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.74M USD -19.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.04M USD -3.55%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.09M USD +2.32%
Operating Lease, Payments 2.4M USD +9.09%
Additional Paid in Capital 645M USD +1.05%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 701K USD -2%
Depreciation, Depletion and Amortization 7.6M USD +4.11%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 22.7M USD +3.07%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%